These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2933456)

  • 21. Alloantigen-reactive Th1 development in IL-12-deficient mice.
    Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA; Kataoka M; Flye WM
    J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
    Phadke K; Carlson DG; Gitter BD; Butler LD
    J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gamma radiation on cytokine expression and cytokine-receptor mediated STAT activation.
    Han SK; Song JY; Yun YS; Yi SY
    Int J Radiat Biol; 2006 Sep; 82(9):686-97. PubMed ID: 17032631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense.
    Mitchell LA; Pearson TW; Gauldie J
    Immunology; 1986 Feb; 57(2):291-6. PubMed ID: 3485076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (IL-2) and interleukin-1 beta (IL-1 beta) in mice splenocytes].
    Arias J; Melean E; Valero N; Pons H; Chacín-Bonilla L; Larreal Y; Bonilla E
    Invest Clin; 2003 Mar; 44(1):41-50. PubMed ID: 12703182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    Malek TR; Robb RJ; Shevach EM
    J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis.
    Thoman ML; Weigle WO
    J Immunol; 1982 May; 128(5):2358-61. PubMed ID: 6460821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a novel murine T cell-activating factor.
    Garman RD; Raulet DH
    J Immunol; 1987 Feb; 138(4):1121-9. PubMed ID: 3543122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
    Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
    J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential induction of IL-4 is determined by the type and duration of antigenic stimulation.
    Saito S; Dorf ME; Watanabe N; Tadakuma T
    Cell Immunol; 1994 Jan; 153(1):1-8. PubMed ID: 8287484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains.
    Hoehn P; Goedert S; Germann T; Koelsch S; Jin S; Palm N; Ruede E; Schmitt E
    J Immunol; 1995 Oct; 155(8):3788-93. PubMed ID: 7561083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of total lymphoid irradiation-induced immunosuppression. II. Failure of con A-stimulated splenocytes from TLI-treated mice to express IL-2 and IL-2 receptor RNA.
    Ye ZX; Becker GC; Field EH
    Transplantation; 1990 Nov; 50(5):839-45. PubMed ID: 2238059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of Tremella polysaccharide on IL-2 production by mouse splenocytes].
    Ma L; Lin ZB
    Yao Xue Xue Bao; 1992; 27(1):1-4. PubMed ID: 1529707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of two immunoregulatory factors--interleukin 2 inhibitors.
    Wu YY; Zhang J; Zhang YH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(2):85-90. PubMed ID: 2798405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.